A Randomized Controlled Trial of a Behavioral Weight Loss Program for Human Immunodeficiency Virus–Infected Patients
Author(s) -
Katie Becofsky,
Edward J. Wing,
Jeanne M. McCaffery,
Matthew W. Boudreau,
Rena R. Wing
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix238
Subject(s) - weight loss , medicine , randomized controlled trial , human immunodeficiency virus (hiv) , quality of life (healthcare) , obesity , immunology , nursing
Obesity compounds the negative health effects of human immunodeficiency virus (HIV) infection. We conducted the first randomized trial of behavioral weight loss for HIV-infected patients (n = 40). Participants randomized to an Internet behavioral weight loss program had greater 12-week weight loss (mean, 4.4 ± 5.4 kg vs 1.0 ± 3.3 kg; P = .02) and improvements in quality of life than controls. Clinical Trials Registration NCT02421406.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom